G211-0101 Screening compound: 2-cyclohexyl-3-oxo-N-[3-(pyrrolidin-1-yl)propyl]-1H,2H,3H-pyrrolo[3,4-b]quinoline-9-carboxamide

G211-0101 Screening compound: 2-cyclohexyl-3-oxo-N-[3-(pyrrolidin-1-yl)propyl]-1H,2H,3H-pyrrolo[3,4-b]quinoline-9-carboxamide
G211-0101 Screening compound: 2-cyclohexyl-3-oxo-N-[3-(pyrrolidin-1-yl)propyl]-1H,2H,3H-pyrrolo[3,4-b]quinoline-9-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G211-0101
2-cyclohexyl-3-oxo-N-[3-(pyrrolidin-1-yl)propyl]-1H,2H,3H-pyrrolo[3,4-b]quinoline-9-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G211-0101

Molecular Formula

C25H32N4O2 (C25 H32 N4 O2)

Compound Name

2-cyclohexyl-3-oxo-N-[3-(pyrrolidin-1-yl)propyl]-1H,2H,3H-pyrrolo[3,4-b]quinoline-9-carboxamide

IUPAC name

2-cyclohexyl-3-oxo-N-[3-(pyrrolidin-1-yl)propyl]-1H2H3H-pyrrolo[34-b]quinoline-9-carboxamide

SMILES

O=C(c1c(CN(C2CCCCC2)C2=O)c2nc2ccccc12)NCCCN1CCCC1

InChI

InChI=1S/C25H32N4O2/c30-24(26-13-8-16-28-14-6-7-15-28)22-19-11-4-5-12-21(19)27-23-20(22)17-29(25(23)31)18-9-2-1-3-10-18/h4-5,11-12,18H,1-3,6-10,13-17H2,(H,26,30)

InChI Key

FLZVYFGPGRSPHR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27210891

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

420.55

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.295

Distribution Coefficient, logD

0.262

Water Solubility, LogSw

-3.54

Polar Surface Area

54.067

Acid Dissociation Constant (pKa)

13.69

Base Dissociation Constant (pKb)

10.43

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

56.00

G211-0101 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Antiviral Library (67538 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with G211-0101 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G211-0101?
Check Price and Availability of G211-0101, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G211-0101 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G211-0101
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G211-0101
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G211-0101 available by request